HROW vs RHI · rev $114.9M vs P/E 21, rev $5.38B
Harrow Health Inc (HROW) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported HROW revenue for 2026-06-30 was $114.9M. Net income was -$44.9M. HROW currently screens at market cap $1.28B.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
HROW currently screens at market cap $1.28B. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the HROW and RHI stock pages for the full models.
Not investment advice.